Efficiency and safety
in NAT testing
PoET is a whole new system for the detection of viral nucleic acids in blood screening.
High performance PCR kits
Highly sensitive NAT tests for HCV, HBV, HIV, HAV, B19V and HEV, with WNV for seasonal testing.
SARS-CoV-2 PCR reagent kit
The PCR reagents have been designed to support screening laboratories during the Corona crisis.
Who we are
GFE was founded in 2005 by the German Red Cross Blood Donation Centres West and NSTOB together with the Blood Donation Centre of the Bavarian Red Cross and quickly turned into a leading company for virus detection by nucleic acid amplification technology (NAT).
GFE’s founders are recognised experts in blood donation diagnostics and are strongly committed to top-level research. They have been influential in developing the techniques and procedures to establish NAT testing as a routine method for blood donor screening in Germany during the 1990s. This ground-breaking work enabled the German Red Cross to be among the first organisations worldwide to reach a new level of blood safety.
GFE offers its customers NAT tests for all transfusion relevant viruses featuring state of the art technologies, like multi-dye and multi-target assays with excellent sensitivity, specificity and robustness against target mutations.
Above all, GFE gladly places its long-standing experience in the field at the customer‘s disposal to assist in planning, integrating and setting up NAT testing logistics, strategies and workflows.
PoET System – Pushing blood screening forward
This is the future of NAT testing in blood screening. A fully automated instrument, sophisticated software and a series of NAT tests make up this powerful solution for blood screening laboratories. Out of the gate, the PoET system features highly sensitive NAT tests for HCV, HBV, HIV, HAV, B19V and HEV, with WNV scheduled to follow this spring for seasonal testing. The PoET Instrument reaches a new level of integration and covers the entire workflow from sample pooling, to sample preparation and PCR testing on a single platform.
DGTI 2022 Mannheim
55th Annual Meeting of the German Society for Transfusion Medicine and Immunohematology e.V. (DGTI), Congress Center Rosengarten Mannheim, Rosengartenpl. 2, 68161 Mannheim, Germany Meet us from the 21st to 23rd of September 2022, booth 49. You'll find all the details...
PoET WNV – now available
A new level of efficiency for WNV screening Frankfurt/Main – GFE today announced the launch of its PoET WNV PCR kit. PoET WNV is a CE-IVD marked test, based on real-time PCR technology, for the detection of West Nile virus RNA in human plasma samples. PoET WNV is...
Market Launch of PoET System – Pushing blood screening forward
Frankfurt/Main – GFE today unveiled its vision for the future of NAT testing in blood screening, the PoET system. A fully automated instrument, sophisticated software and a series of NAT tests make up this powerful solution for blood screening laboratories. Out of the...